Niagen Bioscience, Inc. (NAGE): Shares Outstanding
79.71M
As of 2025-12-31
78.91M
As of 2026-06-30
+2.2%
3-year compound annual growth
+5.2%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 79.71M | +3.1% | 2026-03-04, Balance as of period end |
| 2024-12-31 | 77.33M | +3.1% | 2026-03-04, Balance as of period end |
| 2023-12-31 | 74.98M | +0.6% | 2025-03-04, Balance as of period end |
| 2022-12-31 | 74.57M | +9.5% | 2024-03-06, Balance as of period end |
| 2021-12-31 | 68.13M | +10.1% | 2023-03-08, Balance as of period end |
| 2020-12-31 | 61.88M | +3.9% | 2022-03-14, Balance as of period end |
| 2019-12-31 | 59.56M | n/m | 2021-03-12, Balance as of period end |
| 2018-12-31 | 55.1K | -99.9% | 2020-03-10, Balance as of period end |
| 2017-12-30 | 54.70M | n/c | 2019-03-07, Balance as of period end |
| 2016-12-31 | 37.54M | +4.3% | 2018-03-15, Balance as of period end |
| 2016-01-02, Fiscal 2015 | 36.00M | n/c | 2017-03-16, Balance as of period end |
| 2015-01-03, Fiscal 2014 | 105.27M | +0.7% | 2016-03-17, Balance as of period end |
| 2013-12-28 | 104.52M | +13.4% | 2015-03-19, Balance as of period end |
| 2012-12-29 | 92.14M | +26.3% | 2014-03-27, Balance as of period end |
| 2011-12-31 | 72.94M | +19.8% | 2013-03-29, Balance as of period end |
| 2011-01-01, Fiscal 2010 | 60.88M | n/a | 2012-03-15, Balance as of period end |